References

1. Dixon, J. S.; Gosling, J. A. Textbook of Benign Prostatic Hyperplasia, 2nd ed.; Taylor & Francis: London, 2005, pp 3-10.

2. Turkes, A.; Griffiths, K. Textbook of Benign Prostatic Hyperplasia, 2nd ed.; Taylor & Francis: London, 2005, pp 27-68.

3. Morales, A.; Heaton, J. P; Carson, C. C., III J. Urol. 2000, 163, 705-712.

4. Rhoden, E. L. N. Engl. J. Med. 2004, 350, 482-492.

5. Wang, X.; Stocco, D. M. Mol. Cell. Endocrinol. 2005, 238, 1-7.

6. Wang, X.; Shen, C.-L.; Dyson, M. T.; Eimerl, S.; Orly, J.; Hutson, J. C.; Stocco, D. Endocrinology 2005, 146, 4202-4208.

7. Bosch, J. L.; Hop, W C.; Niemer, A. Q.; Bangma, C. H.; Kirkels, W J.; Schroeder, F H. J. Urol. 1994, 152, 1501-1505.

8. Fujikawa, S.; Matsuura, H.; Kanai, M.; Fumino, M.; Ishii, K.; Arima, K.; Shiraishi, T; Sugimura, Y Prostate 2005, 65, 355-364.

9. AUA Practice Guidelines Committee. J. Urol. 2003, 170, 530-547.

10. Sarma, A. V; Jacobson, D. J.; McGree, M. E.; Roberts, R. O.; Lieber, M. M.; Jacobsen, S. J. J. Urol. 2005, 173, 2048-2053.

11. Verhamme, K. M.; Dieleman, J. P.; Bleumink, G. S.; van der Lei, J.; Sturkenboom, M. C.; Artibani, W; Begaud, B.; Berges, R.; Borkowski, A.; Chappel, C. R. et al. Eur. Urol. 2002, 42, 323-328.

12. Fromont, G.; Chene, L.; Latil, A.; Bieche, I.; Vidaud, M.; Vallancien, G.; Mangin, P; Fournier, G.; Validire, P.; Cussenot, O. J. Urol. 2004,172, 1382-1385.

13. Li, Z.; Habuchi, T; Tsuchiya, N.; Mitsumori, K.; Wang, L.; Ohyama, C.; Sato, K.; Kamoto, T; Ogawa, O.; Kato, T Carcinogenesis 2004, 25, 237-240.

14. Sakamoto, S.; Yokoyama, M.; Zhang, X.; Prakash, K.; Nagao, K.; Hatanaka, T; Getzenberg, R. H.; Kakehi, Y Endocrinology 2004, 145, 2929-2940.

15. Roberts, R. O.; Bergstrath, E. J.; Farmer, S. A.; Jacobson, D. J.; McGree, M. E.; Hebbring, S. J.; Cunningham, J. M.; Anderson, S. A.; Thibodeau, S. N.; Lieber, M. M. et al. Prostate 2005, 62, 380-387.

16. Lee, K. L.; Peehl, D. M. J. Urol. 2004, 172, 1784-1791.

17. Cordon-Cardo, C.; Koff, A.; Drobnjak, M.; Capodieci, P; Osman, I.; Millard, S. S. J. Natl. Cancer. Inst. 1998, 90, 1284-1291.

18. Liu, X.; Wang, L.; Lin, Y; Teng, Q.; Zhao, C.; Hu, H.; Chi, W Prostate 2000, 43, 83-87.

19. Gandour-Edwards, R.; Mack, P C.; deVere-White, R. Wi; Gumerlock, P. H. Prostate Cancer Prostatic Dis. 2004, 7, 321-326.

20. Castro, P.; Giri, D.; Lamb, D.; Ittmann, M. Prostate 2003, 55, 30.

21. Untergasser, G.; Madersbacher, S.; Berger, P Exp. Gerontol. 2005, 40, 121-128.

22. Untergasser, G.; Gander, R.; Lilg, C.; Lepperdinger, G.; Plas, E.; Berger, P Mech. Aging Dev. 2005, 126, 59-69.

24. Shirakawa, T.; Okada, H.; Acharya, B.; Zhang, Z.; Hinata, N.; Wada, Y Prostate 2004, 58, 33-40.

25. Yokota, T; Honda, K.; Tsuruya, Y; Nomiya, M.; Yamaguchi, O.; Gotanda, K.; Constantinou, C. E. Prostate 2004, 58, 156-163.

26. Wang, Wi; Bergh, A.; Damber, J.-E. Prostate 2004, 61, 60-72.

27. Lemack, G. E.; McConnell, J. D. Textbook of Benign Prostatic Hyperplasia; 2nd ed.; Taylor & Francis: London, 2005, pp 113-115.

28. Araki, I.; Du, S.; Kamiyama, M.; Mikami, Y; Matsushita, K.; Komuro, M.; Furuya, Y; Takeda, M. Urology 2004, 64, 1255-1260.

29. Madersbacher, S.; Alivizatos, G.; Nordling, J.; Sanz, C. R.; Emberton, M.; de la Rosette, J. J. M. C. H. Eur. Urol. 2004, 46, 547-554.

30. Jankovic, M. M.; Kosanovic, M. M. Clin. Biochem. 2005, 38, 58-65.

31. Vincentini, C.; Gravina, G. L.; Angelucci, A.; Pascale, E.; D'Ambrosio, E.; Muzi, P; Di Leonardo, G.; Fileni, A.; Tubaro, A.; Festuccia, C. et al. J. Cancer Res. Clin. Oncol. 2004, 130, 217-221.

34. Vesely, S.; Knutson, T; Fall, M.; Damber, J.-E.; Dahlstrand, C. Neurourol. Urodyn. 2003, 22, 301-305.

35. Seim, A.; Hoyo, C.; Ostbye, T; Vatten, L. BJU Int. 2005, 96, 88-92.

36. Andersson, S.-O.; Rashidkhani, B.; Karlberg, L.; Wolk, A.; Johansson, J.-E. BJU Int. 2004, 94, 327-331.

37. Sarma, A. V; Wei, J. T; Jacobson, D. J.; Dunn, R. L.; Roberts, R. O.; Girman, C. J.; Lieber, M. M.; Cooney, K. A.; Schottenfeld, D.; Montie, J. E. et al. Urology 2003, 61, 1086-1091.

38. Rosen, R. C.; Altwein, J.; Boyle, P et al. Eur. Urol. 2003, 44, 637-649.

39. Rule, A. D.; Jacobson, D. J.; Roberts, R. O.; German, C. J.; McGree, M. E.; Lieber, M. M.; Jacobsen, S. J. Kid. Int. 2005, 67, 2376-2382.

41. Roehrborn, C. G.; Schwinn, D. A. J. Urol. 2004, 171, 1029-1035.

42. Crescioli, C.; Morelli, A.; Adorini, L.; Ferruzzi, P; Luconi, M.; Vannelli, G. B.; Marini, M.; Gelmini, S.; Fibbi, B.; Donati, S. J. Clin. Endocrinol. Metab. 2005, 90, 962-972.

43. Srinivasan, D.; Kosaka, A. H.; Daniels, D. V; Ford, A. P.; Bhattacharya, A. Eur. J. Pharmacol. 2004, 504, 155-167.

44. Djavan, B.; Chapple, C. R.; Milani, S.; Marberger, M. Urology 2004, 64, 1081-1088.

46. Roehrborn, C. G.; Boyle, P.; Nickel, J. C.; Hoefner, K.; Andriole, G.; the ARIA3001, ARIA3002 and ARIA3003 Study Investigators. Urology 2002, 60, 434-441.

47. Andriole, G.; Bruchovsky, N.; Chung, L. W K.; Matsumoto, A. M.; Rittmaster, R.; Roehrborn, C.; Russell, D.; Tindall, D. J. Urol. 2004, 172, 1399-1403.

48. Andersson, K. E.; Wyllie, M. G. BJU Int. 2003, 92, 876-877.

50. Kloner, R. A.; Jackson, G.; Emmick, J. T; Mitchell, M. I.; Bedding, A.; Warner, M. R.; Pereira, A. J. Urol. 2004, 172, 1935-1940.

51. Desgrandchamps, F Curr. Opin. Urol. 2004, 14, 17-20.

52. Habib, F K.; Wyllie, M. G. Prostate Cancer Prostatic Dis. 2004, 7, 195-200.

54. Boyle, P; Robertson, C.; Lowe, F; Roehrborn, C. BJU Int. 2004, 93, 751-755.

56. Dinis, P.; Silva, J.; Ribeiro, M. J.; Avelino, A.; Reis, M.; Cruz, F Eur. Urol. 2004, 46, 88-94.

57. Ma, Q.-J.; Gu, X.-Q.; Cao, X.; Zhao, J.; Kong, X.-B.; Li, Y-X.; Cai, S.-Y Asian J. Androl. 2005, 7, 49-54.

58. Kirby, R. S.; O'Leary, M. P; Carson, C. BJU Int. 2005, 95, 103-109.

59. Fong, Y K.; Milani, S.; Djavan, B. Curr. Opin. Urol. 2005, 15, 35-38.

61. Mochtar, C. A.; Kiemeney, L. A. L. M.; van Riemsdijk, M. M.; Barnett, G. S.; Laguna, M. P.; Debruyne, F M. J.; de la Rosette, J. J. M. C. H. Eur. Urol. 2003, 44, 695-700.

62. Laniado, M. E.; Ockrim, J. L.; Marrionaro, A.; Tubaro, A.; Carter, S. S. BJU Int. 2004, 94, 1283-1286.

64. Hedelin, H.; Johansson, N.; Stroberg, P Scand. J. Urol. Nephrol. 2005, 39, 154-159.

65. Kielb, S. J.; Clemens, J. Q. Urology 2005, 66, 392-396.

66. Namiki, S.; Saito, S.; Ishidoya, S.; Tochigi, T.; Ioritani, N.; Yoshimura, K.; Terai, A.; Arai, Y Urology 2005, 66, 147-151.

67. Forrest, J. B.; Schmidt, S. J. Urol. 2004, 172, 2561-2562.

68. Opree, A.; Kress, M. J. Neurosci. 2GGG, 20, 6289-6293.

69. Pontari, M. A.; Ruggieri, M. R. J. Urol. 2GG4, 172, 839-845.

70. Clinical Effectiveness Group (Association for Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 2002 National Guideline for the Management of Prostatitis. www.guideline.gov (accessed Aug 2006).

72. Parsons, C. L.; Rosenberg, M. T; Sassani, P; Ebrahimi, K.; Koziol, J. A.; Zupkas, P. BJU Int. 2GGS, 95, 86-90.

73. Hunskaar, S.; Lose, G.; Sykes, D.; Voss, S. BJU Int. 2GG4, 93, 324-330.

74. Ukimura, O.; Iwata, T.; Ushijima, S.; Suzuki, K.; Honjo, H.; Okihara, K.; Mizutani, Y; Kawauchi, A.; Miki, T Ultrasound Med. Biol. 2GG4, 30, 575-581.

Biography

Mike G Wyllie, BSc, PhD After spells as a lecturer in Edinburgh and at Wyeth Laboratories, Dr Wyllie joined Pfizer in 1984. During the next decade as Director of Biology he was responsible for building up the Pfizer urology and sexual health groups that resulted in the development of doxazosin, sertraline, sildenafil, and darifenacin. Over the period 1994-98 during which both Cardura and Viagra were launched he was Director of Urology at Pfizer, NY. Subsequently, Dr Wyllie created Urodoc Ltd, a strategic planning and medical education company (http://www.urodoc.co.uk), and a specialist urology biopharmaceutics company specializing in urological product development, Plethora Solution PLC (http://www.plethorasolutions.co.uk). He is also chief scientific officer for the medical technology company Zi Medical PLC (http://www.zi-medical.com).

Dr Wyllie has written in excess of 100 articles and is the inventor of almost 90 patents. He is an Assistant Editor (Sexual Medicine Section) of the British Journal of Urology (BJU International) and a member of the European Association Of Urology (EAU), American Urological Association (AUA), and the British Association of Urological Surgeons (BAUS).

© 2007 Elsevier Ltd. All Rights Reserved Comprehensive Medidnal Chemistry II

No part of this publication may be reproduced, stored in any retrieval system or transmitted ISBN (set): 0-08-044513-6 in any form by any means electronic, electrostatic, magnetic tape, mechanical, photocopying, recording or otherwise, without permission in writing from the publishers ISBN (Volume 6) 0-08-044519-5; pp. 551-573

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment